Primary market research
Real-world insights
Connecting biopharma companies with robust provider insights for data-driven product market strategies
Invest in smarter, targeted oncology product planning with primary market research opportunities that will help refine your go-to market strategy, identify barriers to product adoption, and understand cancer care through the eyes of a physician.
Identify barriers and refine your go-to market strategy
Gain insight into the treatment landscape and clinical decision-making with Emerging Perspectives
Whether you’re launching a new drug or have a new indication for an existing product, you need provider input regarding appropriate use and unforeseen challenges to adoption. Through our Emerging Perspectives program, we’ll assemble a panel of physicians to provide case-based feedback on your product using primary market research.
An Emerging Perspectives panel includes:
- A pre-meeting provider-feedback survey on the scenarios you propose
- A facilitated, in-person question and answer session to help the panel better understand your drug
- Quantitative and qualitative assessments to see if product education affected providers' approaches
Robust insights for product development and planning
Gain provider access to understand decision factors and patient care patterns with Challenging Cases®
We'll create a forum of providers to mimic the clinical experience that will allow you to better understand cancer care in real world settings. These live and virtual interactive events will yield insights to help you understand how oncologists treat patients and the drivers behind their treatment decisions.
Challenging Cases can help you identify:
- How and why physicians treat patients (in the clinical setting)
- Leading indicators of providers' awareness, perceptions, and current and future product utilization
- Behavioral influencers, segmentation, and trending
Ready to discover how we can support your brand and product market strategy?
Fill out the form below, and one of our experts will be in touch with you.